Abstract:Background: Interleukin-18 (IL-18), a recently described cytokine produced mainly by macrophages, stimulates interferon-gamma (IFN-gamma) production by natural killer cells and T cells. Although it has been reported that serum IL-18 levels are higher in patients with advanced tuberculosis and acute graft-versus-host disease compared with normal controls, the authors found no reports regarding serum IL-18 levels in patients with malignant solid tumors. The purpose of this study was to determine serum IL-18 levels and their clinical significance in patients with gastric carcinoma. Methods: Peripheral blood samples were obtained from 94 patients with gastric carcinoma who underwent curative surgery and from 50 healthy volunteers. The serum IL-18 level, the IFN-gamma, level, and the Helicobacter pylori (HP) serology status were determined in each sample with an enzyme-linked immunosorbent assay. Results: The mean serum IL-18 level for all patients was significantly higher compared with the mean level in healthy volunteers (P < 0.01). IFN-gamma titers were below the level of detection in all samples tested. When the patients were subdivided into groups, it was found that the serum IL-18 level in patients with Stage II and III disease was significantly higher compared with the level found in healthy volunteers (P < 0.01). The serum IL-18 level decreased after patients underwent surgical resection. However, there was no significant difference in the serum IL-18 level between healthy controls and patients with Stage I or IV disease. Patients with IL-18 levels >or= 310 pg/mL (i.e., equal to or greater than the mean levels +/- 1 standard deviation in the healthy volunteers) experienced a significantly lower survival rate compared with patients who had IL-18 levels < 310 pg/mL after undergoing surgery (P < 0.05) despite a lack of any discernible difference in clinicopathologic factors between the two groups. The serum IL-18 level was identified as an independent postoperative prognostic factor in multivariate survival analysis using a Cox proportional hazards model (hazard ratio, 4.89; P = 0.01). There was no significant correlation between HP serology status and serum IL-18 levels. Conclusions: The preoperative serum IL-18 level may represent a significant postoperative prognostic determinant in patients with gastric carcinoma. Its function in the host immune system remains to be elucidated.

Relationship of Serum Interleukin-18 and Interleukin-12 Levels with Clinicopathology in Renal Cell Carcinoma

SERUM INTERLEUKIN-18 LEVEL AS A PROGNOSTIC MARKER IN PATIENTS WITH COLORECTAL CARCINOMA

Clinical Significance of Tumor-Derived IL-1β and IL-18 in Localized Renal Cell Carcinoma: Associations with Recurrence and Survival1contributed Equally to This Work.

[Relationship Between Interleukin-10 Level in Ascites of Patients with Primary Ovarian Epithelial Carcinoma and Immune Defect in Peritoneal Cavity].

Serum interleukin-18 as a prognostic factor for hepatocellular carcinoma patients

Serum Cytokine Levels in Patients with Advanced Non-Small Cell Lung Cancer: Correlation with Treatment Response and Survival.

Study on the correlationship between CK19mRNA and CyFRA21-1 in peripheral blood of lung cancer patients

Serum Levels and Clinical Significance of IL-18 and IL-1βin Patients with Gastric Cancer

Clinical Value of Serum Interleukin-18 in Patients with Prostate Cancer

Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma

Expression of IL-4 and IL-13 Predicts Recurrence and Survival in Localized Clear-Cell Renal Cell Carcinoma

The Expression of Serum IL-6, IL-10, IL-12 Level in Gastrointestinal Neoplasm and Its Significance

High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.

Preoperative Levels of Serum Interleukin-6 in Patients with Hepatocellular Carcinoma.

Levels of serum IL-18 and IL-34 in patients with lupus nephritis and their significance

Elevated Plasma Interleukin-35 As a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma

Serum interleukin 18 level in kidney diseases and age

Correlation of plasma interleukin-18 concentration and severity of renal involvement and disease activity in systemic lupus erythematosus

Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.

IL-6, IL-8 and TNF-α Levels Correlate with Disease Stage in Breast Cancer Patients

Analysis of the Co-relationship Between 6 Kinds Cytokines Level in Serum and Cancer Staging in Patients with Head and Neck Squamous Cell Carcinoma